When Her Daughter Was Diagnosed With A Rare Disease, This Accountant ...

Karen Aiach, 43, is the founder and CEO of Lysogene, a biotech company developing gene therapy treatments for rare central nervous system diseases. Remarkably, the French native had no background in science or the pharmaceutical industry, let alone ...